Novel targets to treat airway fibrosis [ 2012 - 2015 ]

Also known as: new therapies to treat airway scaring

Research Grant

[Cite as]

Researchers: A/Pr Brian Oliver (Principal investigator)

Brief description Airway fibrosis or scaring causes significant morbidity in both chronic obstructive pulmonary disease (COPD) and asthma . These diseases affect 10-15% of the population, and cost the health system $1.15 billion per year. Airway fibrosis is not decreased by the current therapeutics used to treat COPD and asthma, and as such there is a pressing need to develop therapeutics to specifically treat airway fibrosis. Dr Brian Oliver has partnered with Pharmaxis to develop new therapeutics to specifically treat fibrosis

Funding Amount $AUD 422,685.45

Funding Scheme Career Development Fellowships

Notes Industry CDF

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]